Intervention Protocol

You have free access to this content

The impact of biological interventions for ulcerative colitis on health-related quality of life

  1. Katie LeBlanc1,*,
  2. Mahmoud Mosli2,3,
  3. Kenneth A Baker4,
  4. John K MacDonald4

Editorial Group: Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group

Published Online: 6 JUN 2013

DOI: 10.1002/14651858.CD008655.pub2


How to Cite

LeBlanc K, Mosli M, Baker KA, MacDonald JK. The impact of biological interventions for ulcerative colitis on health-related quality of life (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD008655. DOI: 10.1002/14651858.CD008655.pub2.

Author Information

  1. 1

    Robarts Research Institute, c/o Robarts Clinical Trials, London, Ontario, Canada

  2. 2

    London Health Sciences Centre, Victoria Hospital, London, Ontario, Canada

  3. 3

    King Abdulaziz University, King Abdulaziz University Hospital, Jeddah, Saudi Arabia

  4. 4

    Robarts Research Institute, Robarts Clinical Trials, London, Ontario, Canada

*Katie LeBlanc, c/o Robarts Clinical Trials, Robarts Research Institute, PO Box 5015, 100 Perth Drive, London, Ontario, N6A 5K8, Canada. cathy.leblanc@utoronto.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 6 JUN 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary objective is to systematically assess the impact of biologic therapy on the QoL of ulcerative colitis patients.